CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01381718
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:32.555520+00:00
Published At: 2021-08-13T00:00:00+00:00
Record Updated At: 2021-08-13
Results Posted At: 2021-08-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Brain and Central Nervous System Tumors", "Cognitive/Functional Effects", "Fatigue", "Neurotoxicity", "Psychosocial Effects of Cancer and Its Treatment"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-08-13"
protocolSection.identificationModule.nctId: "NCT01381718"
protocolSection.identificationModule.officialTitle: "A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-08-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.